May 12, 2020 / 7:08 AM / 16 days ago

BRIEF-Hikma Launches Propofol Injectable Emulsion, USP, In Response To COVID-19 Shortage

May 12 (Reuters) - Hikma Pharmaceuticals PLC:

* HIKMA RESPONDS TO COVID-19 SHORTAGE WITH LAUNCH OF PROPOFOL INJECTABLE EMULSION, USP

* HIKMA - LAUNCH OF PROPOFOL INJECTABLE EMULSION, USP, 20 ML, 50 ML AND 100 ML VIALS, IN UNITED STATES

* HIKMA - PROPOFOL INJECTABLE EMULSION IS CURRENTLY ON FDA’S DRUG SHORTAGE LIST, FOLLOWING A SURGE IN DEMAND DURING COVID-19 PANDEMIC

* HIKMA - FOCUSED OUR US AND GLOBAL MANUFACTURING CAPABILITIES ON PRODUCING MEDICINES THAT ARE IN HIGHEST DEMAND DUE TO OUTBREAK OF COVID-19 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below